Highlights and Quick Summary
- Assets Liabilities Change (Total) for the quarter ending September 30, 2023 was $2.4 Million (a -142.95% decrease compared to previous quarter)
- Year-over-year quarterly Assets Liabilities Change (Total) increased by 104.87%
- Annual Assets Liabilities Change (Total) for 2022 was $-35.4 Million (a -213.55% decrease from previous year)
- Annual Assets Liabilities Change (Total) for 2021 was $31.2 Million (a 18909.76% increase from previous year)
- Twelve month Assets Liabilities Change (Total) ending September 30, 2023 was $-10.6 Million (a -37.01% decrease compared to previous quarter)
- Twelve month trailing Assets Liabilities Change (Total) decreased by -69.97% year-over-year
Trailing Assets Liabilities Change (Total) for the last four month:
| 30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
|---|---|---|---|
| $-10.6 Million | $-16.9 Million | $-9.73 Million | $-35.4 Million |
Visit stockrow.com/PRME
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Assets Liabilities Change (Total) of Prime Medicine, Inc.
Most recent Assets Liabilities Change (Total)of PRME including historical data for past 10 years.Interactive Chart of Assets Liabilities Change (Total) of Prime Medicine, Inc.
Prime Medicine, Inc. Assets Liabilities Change (Total) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $2.4 | $-5.59 | $-8.62 | – | – |
| 2022 | $1.17 | $-3.85 | $1.57 | $-34.29 | $-35.4 |
| 2021 | – | – | $31.56 | $-0.39 | $31.18 |
| 2020 | $0.16 | – | – | – | $0.16 |
Business Profile of Prime Medicine, Inc.
Sector: Healthcare
Industry: Biotechnology